Quarterly Report (10-q)

S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Quarterly Report (10-q)

This article is 7Mb in size. Click here to view

NanoViricides (AMEX:NNVC)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more NanoViricides Charts.

NanoViricides (AMEX:NNVC)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more NanoViricides Charts.

Nanoviricides, Inc. News

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 27 September 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 9 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 9 August 2024 (2 months ago) • Edgar (US Regulatory)

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
Thursday 2 May 2024 (5 months ago) • InvestorsHub NewsWire

Form 8-K - Current report
Friday 16 February 2024 (8 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 February 2024 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 19 January 2024 (9 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 4 December 2023 (10 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 13 October 2023 (12 months ago) • Edgar (US Regulatory)

More Nanoviricides, Inc. News Articles

Accredited Solutions (PK)

Laser Photonics

Halozyme Therapeutics

Asia Broadband (PK)

Enzolytics (PK)

TPT Global Tech (PK)

Valiant Eagle (PK)

Digital Brand Media and ... (PK)

Anavex Life Sciences

RespireRx Pharmaceuticals (CE)

Sincerity Applied Materi... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions